Capitol Hill staffers are working around the clock to hammer into some twisted shape a spending bill that warring factions of the Democratic Party will support in their goal to transform America. The cradle-to-grave subsidies in the 2,448-page, $3.5 trillion spending bill that Democrats in Congress are crafting will create a welfare trap for millions more Americans, send inflation soaring, and … [Read more...] about Democrats’ Destructive Spending Spree Would Turn America Into a European Social Welfare State
“Tough” Choices for Dems — Brian Blase in NRO
What to Cut? Start with the Subsidies to Health-Insurance CompaniesBy Brian BlaseNational Review Online, Oct. 12, 2021 The news is full of stories about the “tough” choices that congressional Democrats must make to trim their massive $3.5 trillion reconciliation package. Here’s an easy one — eliminate the $600 billion in subsidies to health-insurance companies in the proposed legislation, Galen … [Read more...] about “Tough” Choices for Dems — Brian Blase in NRO
Read the Bill!
It may seem like things have quieted down in Washington, but don’t be fooled. Staffers are working around the clock to hammer into some twisted shape a reconciliation bill that can get support from the warring factions of their party to “transform America.” Prof. Chuck Blahous analyzed the 2,448-page $3.5 trillion+ reconciliation bill that Democrats in Congress are working … [Read more...] about Read the Bill!
Faltering Agenda?
Hugely consequential and transformative policy and spending decisions often are hidden from Americans behind the complex web of congressional procedures—and, of course, back-room deals. And this could not be more true right now. The ultra-liberal progressive caucus in Congress, with nearly 100 votes, is threatening to block passage of the $550 billion infrastructure bill that already has … [Read more...] about Faltering Agenda?
Drug Price Controls Threaten Biotech Research and Patients
There are too many dreadful provisions in Democrats’ $3.5 trillion spending monstrosity to count, but one is rising to the surface as especially destructive. That would be its prescription drug price-control schemes. A study by University of Chicago economist Tomas Philipson and analyst Troy Durie concludes that the Congressional Budget Office is wrong by more than an order of … [Read more...] about Drug Price Controls Threaten Biotech Research and Patients
Medicaid Blowout
“Medicaid now covers 1 in 4 Americans, but Congress may soon lock even more into an expensive program with inadequate access to doctors and poor health outcomes,” Brian Blase writes today in a Wall Street Journal op-ed, “The Next Medicaid Blowout.” “One section of the $3.5 trillion bill Democrats are trying to push through Congress would create a new federal Medicaid program to cover mainly … [Read more...] about Medicaid Blowout
Incalculable losses
There are too many dreadful provisions in the Democrats’ $3.5 trillion monstrosity to count, but one is rising to the surface as especially destructive: Its prescription drug price control schemes. University of Chicago economist Tomas J. Philipson explained the details and the impact of the pending legislation in a Wall Street Journal op-ed yesterday. He … [Read more...] about Incalculable losses
More expansive than Obamacare
Congressional committees are working feverishly on the largest single spending bill in the nation’s history—a mind-boggling $3.5 trillion blowout that would dramatically expand the welfare state and make Americans beholden to the federal government for decades to come, “a cradle-to-grave entitlement agenda…that would transform America.” The chief architect is … [Read more...] about More expansive than Obamacare